For a 35-year-old woman with hypertension (blood pressure 167/87 mm Hg), who smokes cigarettes and uses marijuana, has irregular menstrual periods, and needs a refill of depot medroxyprogesterone acetate (DMPA) injection, what is the appropriate contraceptive management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

DMPA Refill is Appropriate with Blood Pressure Management

You can safely provide the DMPA (Depo-Provera) refill for this patient, as progestin-only contraceptives like DMPA do not raise blood pressure and are not contraindicated in hypertensive women who smoke. However, her significantly elevated blood pressure (167/87 mmHg) requires immediate attention and treatment initiation.

Contraceptive Management

DMPA is Safe in This Clinical Context

  • Progestin-only methods like DMPA are appropriate for women with hypertension and smoking, unlike combined hormonal contraceptives (CHCs) which contain estrogen 1
  • DMPA does not increase cardiovascular risk and research demonstrates it actually lowers blood pressure rather than raising it 2
  • The combination of smoking and hypertension would make estrogen-containing contraceptives (combined oral contraceptives, patch, ring) contraindicated, but DMPA contains no estrogen 3

Administration Protocol

  • Administer DMPA 150mg intramuscularly today if she is within the appropriate window for refill 1
  • DMPA can be given up to 2 weeks late (15 weeks from last injection) without requiring backup contraception 4
  • If uncertain about pregnancy status, the benefits of starting DMPA exceed any risk; proceed with injection and follow up with pregnancy test in 2-4 weeks 1
  • No physical examination or blood pressure measurement is required before DMPA administration (Class C examination per CDC guidelines), though you already have her BP 1

Hypertension Management - The Priority Issue

Immediate Action Required

This patient has Stage 2 hypertension (systolic ≥140 or diastolic ≥90 mmHg) and requires:

  • Initiate antihypertensive medication today - do not delay treatment
  • Target BP <130/80 mmHg for a 35-year-old
  • Her smoking status increases cardiovascular risk, making BP control even more critical for reducing morbidity and mortality

Smoking Cessation Counseling

  • Cigarette smoking is her most modifiable cardiovascular risk factor at age 35
  • Provide smoking cessation resources, consider pharmacotherapy (varenicline, bupropion, or nicotine replacement)
  • Marijuana use does not contraindicate DMPA but discuss cardiovascular effects of smoking

Addressing Irregular Bleeding

Expected DMPA Effects

  • Irregular bleeding is the most common side effect of DMPA, especially in early use 5
  • By 12 months of use, 55% of women experience amenorrhea; by 24 months, 68% have amenorrhea 5
  • If she desires treatment for irregular bleeding, offer NSAIDs for 5-7 days as first-line management 1

When to Investigate Further

  • Rule out pregnancy if bleeding pattern changes significantly
  • Investigate for organic pathology only if bleeding is severe, heavy, or continuous 5
  • Consider STI testing, thyroid disorders, or uterine pathology if clinically indicated 1

Critical Counseling Points

DMPA-Specific Warnings

  1. Bone mineral density loss: DMPA causes reversible BMD decrease, though this is less concerning at age 35 than in adolescents 5
  2. No STI protection: Counsel that DMPA does not protect against HIV or other sexually transmitted infections 5
  3. Return to fertility: May take up to 10 months after last injection for fertility to return
  4. Continuation: Encourage return in 12 weeks (can extend to 15 weeks) for next injection 4

Common Pitfall to Avoid

Do not withhold DMPA due to elevated blood pressure - this is a common error. The concern about hypertension and contraception applies to estrogen-containing methods only. DMPA is actually one of the safest contraceptive options for hypertensive women 3.

Follow-Up Plan

  • Blood pressure recheck in 2-4 weeks after starting antihypertensive therapy
  • DMPA reinjection in 12 weeks (or up to 15 weeks)
  • Smoking cessation follow-up
  • Contact provider anytime for concerning bleeding, side effects, or questions 4

The evidence strongly supports continuing DMPA in this patient while simultaneously addressing her more serious cardiovascular risk factors 1, 3, 2.

References

1
Guideline

u.s. selected practice recommendations for contraceptive use, 2024.

MMWR Recommendations and Reports, 2024

2
Research

The effect of medroxyprogesterone acetate on blood pressure.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1978

Related Questions

What should be done if a patient insists on receiving the Depo‑Provera (medroxyprogesterone acetate) injection despite a hypertensive emergency?
Is Depo‑Provera (medroxyprogesterone acetate) contraindicated in a patient with a blood pressure of 215/151 mm Hg?
Can a 28-year-old woman who has been using depot medroxyprogesterone acetate (Depo‑Provera) for three years switch to a combined oral contraceptive pill?
Can a healthy 45-year-old woman safely start depot medroxyprogesterone acetate (Depo‑Provera) for contraception?
How should dizziness and headache be evaluated and managed in a reproductive‑age woman after a medroxyprogesterone acetate depot (Depo‑Provera) injection?
In a 58-year-old man with mildly low total testosterone, what further testing is recommended?
Is it appropriate to administer aztreonam twice daily (bid) for a serious gram‑negative infection in a patient with normal renal function?
In a 22-year-old woman with left lower quadrant abdominal pain, no fever, and a menstrual period due in four days, what is the appropriate next step in evaluation and management?
Should a patient with a first-degree relative who had breast cancer undergo mammographic screening?
A patient has been taking Contrave (naltrexone 8 mg/bupropion 90 mg) for 8 weeks and reports that the appetite‑suppressing effect has diminished; is this expected?
What is the rotigotine transdermal patch equivalent for a Dotti patch delivering 0.05 mg per 24 hours?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.